This new peer-reviewed publication describes viruses isolated from patient samples from the first and second wave of COVID-19 in Houston, Texas last spring.
Of note the authors analyzed the nsp12 polymerase gene that encodes for an RNA-dependent RNA polymerase (RdRp; also referred to as Nsp12) used in viral replication. As Remdesivir, the adenosine analog used as a COVID-19 therapy, is inserted into the RNA chain by this RNA polymerase conferring inhibition of viral replication, it is important to ascertain the prevalence of variations in RdRp.
Additionally the authors reveal the mutational analysis of the SARS-CoV-2 spike protein including the dominant aspartic acid to glycine amino acid mutation at the 614 position (D614G) depicted in Figure 6 below. The researchers show this single amino acid substitution confers a higher viral load in patient samples which likely results in higher transmission and infectivity.
A link to the full research article is available here.
KEY FIGURES:
Figure 1:
ABSTRACT:
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in metropolitan Houston, TX, an ethnically diverse region with 7 million residents. The genomes were from viruses recovered in the earliest recognized phase of the pandemic in Houston and from viruses recovered in an ongoing massive second wave of infections. The virus was originally introduced into Houston many times independently. Virtually all strains in the second wave have a Gly614 amino acid replacement in the spike protein, a polymorphism that has been linked to increased transmission and infectivity. Patients infected with the Gly614 variant strains had significantly higher virus loads in the nasopharynx on initial diagnosis. We found little evidence of a significant relationship between virus genotype and altered virulence, stressing the linkage between disease severity, underlying medical conditions, and host genetics. Some regions of the spike protein—the primary target of global vaccine efforts—are replete with amino acid replacements, perhaps indicating the action of selection. We exploited the genomic data to generate defined single amino acid replacements in the receptor binding domain of spike protein that, importantly, produced decreased recognition by the neutralizing monoclonal antibody CR3022. Our report represents the first analysis of the molecular architecture of SARS-CoV-2 in two infection waves in a major metropolitan region. The findings will help us to understand the origin, composition, and trajectory of future infection waves and the potential effect of the host immune response and therapeutic maneuvers on SARS-CoV-2 evolution.
IMPORTANCE:
There is concern about second and subsequent waves of COVID-19 caused by the SARS-CoV-2 coronavirus occurring in communities globally that had an initial disease wave. Metropolitan Houston, TX, with a population of 7 million, is experiencing a massive second disease wave that began in late May 2020. To understand SARS-CoV-2 molecular population genomic architecture and evolution and the relationship between virus genotypes and patient features, we sequenced the genomes of 5,085 SARS-CoV-2 strains from these two waves. Our report provides the first molecular characterization of SARS-CoV-2 strains causing two distinct COVID-19 disease waves.
Figure 6:
DOI: 10.1128/mBio.02707-20